Australia Stock Exchange release from PARADIGM BIOPHAR : PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION
26/09/2021 23:23
Australia Stock Exchange release from PARADIGM BIOPHAR PAR.AX : PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt